Literature DB >> 9819950

Personality disorder as a contraindication for liver transplantation in alcoholic cirrhosis.

W R Yates1, D R LaBrecque, D Pfab.   

Abstract

Severe personality disorder has been proposed as a contraindication for liver transplantation. Seventy-three subjects with alcoholic-related liver disease were evaluated for personality disorder and followed for 6 months. The subjects with severe personality disorder had higher rates of divorce, higher rates of comorbid drug abuse or dependence, lower Weschler Adult Inventory Scale IQ estimates, and higher scores on indicators of emotional impairment. Personality disorder was not associated with a higher rate of return to alcohol use during the follow-up period. Three subjects with personality disorder underwent liver transplantation without behavioral or substance abuse complications. This study does not support routine exclusion of subjects based solely on a diagnosis of a severe personality disorder.

Entities:  

Mesh:

Year:  1998        PMID: 9819950     DOI: 10.1016/S0033-3182(98)71282-4

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  3 in total

1.  Individual and environmental correlates and predictors of early adherence and outcomes after liver transplantation.

Authors:  Carol S Stilley; Andrea F DiMartini; Michael E de Vera; William B Flynn; Jennifer King; Susan Sereika; Ralph E Tarter; Mary Amanda Dew; Geetha Rathnamala
Journal:  Prog Transplant       Date:  2010-03       Impact factor: 1.065

2.  Liver transplant recipients: individual, social, and environmental resources.

Authors:  Carol S Stilley; Andrea F DiMartini; Ralph E Tarter; Michael DeVera; Susan Sereika; Mary Amanda Dew; Jennifer King; William B Flynn
Journal:  Prog Transplant       Date:  2010-03       Impact factor: 1.065

Review 3.  Alcohol misuse in patients with alcohol-related liver disease: How can we do better? A narrative review of the literature.

Authors:  Jane Horrell; Lynne Callaghan; Ashwin Dhanda
Journal:  Alcohol Clin Exp Res       Date:  2022-07-08       Impact factor: 3.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.